BIOTEST AG

In News

Osborne Clarke advised Grifols S.A. on the conversion of Biotest AG into a GmbH & Co. KGaA. - Osborne Clarke

Osborne Clarke - Apr 16, 2026

YIMMUGO® Now Available in the U.S.: Kedrion Biopharma Commercializes a New Ig Therapy for PI - PR Newswire

PR Newswire - Oct 09, 2025

Grifols secures first EU approval for fibrinogen concentrate Prufibry in Germany - Manufacturing Chemist

Manufacturing Chemist - Nov 14, 2025

Ashurst advises Biotest on the public delisting offer by GRIFOLS and its delisting from the Frankfurt Stock Exchange - Ashurst Perkins Coie

Ashurst Perkins Coie - Jun 12, 2025

Grifols Buys Biotest as Creat Pushed to Exit Blood-Plasma Stakes - Bloomberg.com

Bloomberg.com - Sep 17, 2021

Grifols agrees to acquire Tiancheng Pharmaceutical for $1.3bn - Pharmaceutical Technology

Pharmaceutical Technology - Sep 20, 2021

FDA Approves the Intravenous Immunoglobulin G Yimmugo to Treat Primary Immunodeficiencies - Pharmacy Times

Pharmacy Times - Jun 17, 2024

ADMA Biologics to Acquire Certain Assets from Biotest Pharmaceuticals Corporation - New Jersey Business Magazine

New Jersey Business Magazine - Jan 23, 2017

IgM-enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices - Wiley Online Library

Wiley Online Library - Jul 19, 2022

Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors - Business Wire

Business Wire - Nov 08, 2024

Biotest AG : Notification and public disclosure of transactions by persons - marketscreener.com

marketscreener.com - Jan 22, 2018

Jörg Schüttrumpf - PharmaTimes

PharmaTimes - Oct 05, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment